Healthcare -
Biotechnology - NASDAQ - BM
$ 20.28
3.31 %
$ 1.47 B
Market Cap
-33.8
P/E
KNSA - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities KNSA - Kiniksa Pharmaceuticals, Ltd.
-29.6 M
LAST VALUE
-10.90%
2 YEAR CAGR
34.18%
5 YEAR CAGR
0.00%
10 YEAR CAGR